• Cleveland Medical Devices (CleveMed; Cleveland) has launched a large-scale multicenter clinical study to continue development and validation of Kinesia, a compact wireless system for monitoring severity of Parkinson's disease (PD) motor symptoms. Kinesia uses miniature motion sensors worn on the hand and wirelessly transmits motor symptom information to a PC. Data is collected while patients follow computer-based video instructions which guide them through various arm and hand movements. In the study, Kinesia will be used to quantify symptoms including tremor, bradykinesia (slowed movements) and dyskinesias (wild involuntary movements) in the clinic and at patients' homes. Data collected during the study will be used to validate existing Kinesia algorithms for automated tremor scoring as well as aid in development of new algorithms for automated bradykinesia and dyskinesia scoring.

• Covidien (Boulder, Colorado) reported the introduction of the Mallinckrodt SealGuard Evac endotracheal tube. The SealGuard Evac tube uses a tapered-shape cuff made from an ultrathin material that virtually eliminates microaspiration of secretions into the lungs while providing secretion drainage through an integrated suction lumen. The new design and technology have been clinically demonstrated to reduce the incidence of both early- and late-onset ventilator-associated pneumonia (VAP), an important breakthrough for long-term intubation. Subglottic secretions drainage performed with the SealGuard Evac tube has been shown to reduce VAP by up to 75%.

No Comments